| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - Remedica 93 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | 21.300 | 21.083 | 20.726 | 20.346 | 19.952 | 19.573 | 19.139 | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 21.265 | 21.048 | 20.692 | 20.312 | 19.919 | 19.541 | 19.108 | - | - | - |
| Cash | 35 | 35 | 34 | 34 | 33 | 32 | 32 | - | - | - |
| Shareholders Funds | -82.503 | -81.661 | -80.280 | -78.806 | -77.280 | -75.815 | -74.134 | - | - | - |
| Social Capital | 67 | 67 | 66 | 64 | 0 | 62 | 61 | - | - | - |
| Debts | 103.803 | 102.744 | 101.005 | 99.152 | 97.232 | 95.388 | 93.273 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Remedica 93 S.r.l.